1-(2-methoxybenzyl)piperidin-4-one | 562840-43-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: 1-(2-methoxybenzyl)piperidin-4-one
• 英文别名: 1-(2-methoxybenzyl)-4-piperidone；1-(2-Methoxybenzyl)-4-piperidinone；1-[(2-methoxyphenyl)methyl]piperidin-4-one
• CAS: 562840-43-1
• 化学式: C₁₃H₁₇NO₂
• mdl: MFCD09743801
• 分子量: 219.283
• InChiKey: LHQSKCWOHDSSLH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.461
• 拓扑面积：
  29.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  1-(2-methoxybenzyl)piperidin-4-one 在 三乙酰氧基硼氢化钠 、 溶剂黄146 、 三氟乙酸 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 5.0h， 生成 1'-(2-methoxybenzyl)-1,4'-bipiperidin-4-amine
  参考文献：
  名称：

  Synthesis of Monomeric Derivatives To Probe Memoquin’s Bivalent Interactions

  摘要：

  Eight monomeric congeners, related to the multitarget lead candidate memoquin, were prepared and evaluated at multiple targets to determine their profile against Alzheimer's disease. 2-4 bind to AChE with similar low nanomolar affinities and function as effective inhibitors of amyloid aggregation. The most potent monovalent ligand 2 also inhibits BACE-1 in vitro and APP metabolism in primary chicken telencephalic neurons.

  DOI：

  10.1021/jm200691d
• 作为产物：
  描述：

  1-(2-methoxybenzyl)-4-piperidinone hydrochloride 在 碳酸氢钠 作用下， 以 二氯甲烷 、 水 为溶剂， 以62.8%的产率得到1-(2-methoxybenzyl)piperidin-4-one
  参考文献：
  名称：

  EP1460062

  摘要：

  公开号：

文献信息

• Green Chemistry Approach to the Synthesis of N-Substituted Piperidones
  作者：Margaret M. Faul、Michael E. Kobierski、Michael E. Kopach

  DOI：10.1021/jo026848i

  日期：2003.7.1

  An efficient green chemistry approach to the synthesis of N-substituted piperidones and piperidines was developed and applied to the synthesis of 1-(2-pyridinylmethyl)-piperidin-4-one, 1, a key starting material for the synthesis of LY317615, an antiangiogenic agent currently under development at Eli Lilly and Company (Chart 1).(1) The general utility of this methodology, which presents significant

  已开发出一种有效的绿色化学方法，用于合成N-取代的哌啶酮和哌啶，并将其应用于1-（2-吡啶基甲基）-哌啶-4-酮1的合成，这是合成LY317615（一种LY317615）的关键原料。礼来公司目前正在开发抗血管生成剂（图1）。（1）直接合成一系列化合物也证明了该方法的通用性，与经典的Dieckman方法相比，该方法具有明显的优势。取代哌啶酮和哌啶，包括潜在的多巴胺D4受体拮抗剂2和3，已在临床上作为抗精神病药进行了评估（图2）。（2）
• Nitrogeneous cyclic ketone derivative, process for producing the same, and use
  申请人：Yamaoka Masayoshi

  公开号：US20050038072A1

  公开（公告）日：2005-02-17

  A novel compound represented by the formula (I): wherein rings A and B each represents an optionally substituted aromatic ring, or rings A and B may be bonded to each other through linking between bonds or substituents thereof to form a ring; ring C represents a nitrogenous saturated heterocycle optionally having one or more substituents besides the oxo (provided that 2,3-dioxopyrrolidine ring is excluded); R 1 represents hydrogen, an optionally substituted hydrocarbon group, or an optionally substituted heterocyclic group; and indicates a single bond or a double bond. It has high antagonistic activity against a tachykinin receptor, especially an SP receptor.

  一种新的化合物，化学式表示为（I）：其中环A和环B分别代表一个可选取代芳香环，或者环A和环B通过键或它们的取代基之间的连接结合形成一个环；环C代表一个氮饱和杂环，除了氧代（提供2,3-二氧代吡咯烷环除外）之外，还可以选择具有一个或多个取代基；R1代表氢、可选取代的碳氢基团或可选取代的杂环基团；表示单键或双键。它对一种快速激动肽受体，尤其是SP受体具有高拮抗活性。
• NITROGENOUS CYCLIC KETONE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND USE
  申请人：Takeda Chemical Industries, Ltd.

  公开号：EP1460062A1

  公开（公告）日：2004-09-22

  A novel compound represented by the formula (I): wherein rings A and B each represents an optionally substituted aromatic ring, or rings A and B may be bonded to each other through linking between bonds or substituents thereof to form a ring; ring C represents a nitrogenous saturated heterocycle optionally having one or more substituents besides the oxo (provided that 2,3-dioxopyrrolidine ring is excluded); R1 represents hydrogen, an optionally substituted hydrocarbon group, or an optionally substituted heterocyclic group; and --------¯ indicates a single bond or a double bond. It has high antagonistic activity against a tachykinin receptor, especially an SP receptor.

  一种由式(I)代表的新型化合物： 其中，环 A 和环 B 各自代表一个任选取代的芳香环，或环 A 和环 B 可通过其键或取代基之间的连接而相互键合，形成一个环；环 C 代表一个含氮饱和杂环，除了氧代外，还可任选具有一个或多个取代基（前提是不包括 2,3-二氧代吡咯烷环）；R1 代表氢、任选取代的烃基或任选取代的杂环基；以及 --------¯ 表示单键或双键。它对速激肽受体，尤其是 SP 受体具有很高的拮抗活性。
• FILAMIN A-BINDING ANTI-INFLAMMATORY ANALGESIC
  申请人：Burns Barbier Lindsay

  公开号：US20110105484A1

  公开（公告）日：2011-05-05

  A compound, its pharmaceutically acceptable salt, a composition containing the same and method of treatment that can provide analgesia and/or reduce inflammation are disclosed. A contemplated compound has a structure that corresponds to Formula A, wherein G, W, Q, Z, D, E, F, K, Y, d, e, f, k, n, m, and circle B and all R groups are defined within.
• US8580808B2
  申请人：——

  公开号：US8580808B2

  公开（公告）日：2013-11-12